Skip to main content
OpenTrials

Clinical trial condition

Intestinal Neoplasms

Explore clinical trials studying Intestinal Neoplasms. Study availability and eligibility vary by location and protocol.

6,367 public trials 1,371 recruiting studies
Refine in advanced search Browse all conditions

Intestinal Neoplasms trial results

Completed

Study Assessing Potential Predictive Tumor Markers in Metastatic Colorectal Cancer

NCT01288339

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • Hospital General Universitario de Elche Elche, Alicante, Spain
  • Hospital Son Espases de Mallorca Palma de Mallorca, Balearic Islands, Spain
  • Hosptial Son Llatzer de Mallorca Palma de Mallorca, Balearic Islands, Spain
  • Hosptial General de l'Hospitalet de Barcelona L'Hospitalet de Llobregat, Barcelona, Spain
View all 30 locations
View Trial Details
Completed

Phase 1 and 2 Study of PX-866 and Cetuximab

NCT01252628

Conditions
Carcinoma, Carcinoma, Squamous Cell, Colonic Diseases, +30 more
Locations
  • Birmingham Hematology and Oncology Assocs. Birmingham, Alabama, United States
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • Southwest Cancer Care Escondido, California, United States
  • Monterey Bay Oncology Monterey, California, United States
View all 40 locations
View Trial Details
Completed

Vectibix for the Treatment of Anal Cancer

NCT01285778

Conditions
Anal Squamous Cell Carcinoma, Anus Diseases, Anus Neoplasms, +11 more
Locations
  • Hospital Universitario Germans Trias i Pujol. Institut Català Oncologia Badalona, Barcelona, Spain
  • Corporació Sanitaria Parc Taulí Sabadell, Barcelona, Spain
  • Hospital Infanta Sofía San Sebastián de los Reyes, Madrid, Spain
  • Centro Oncológico de Galicia A Coruña, Spain
View all 20 locations
View Trial Details
Completed

Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus a Sodium Picosulfate and Magnesium Salt Solution Using Day Before-Only Dosing Regimen in Adults.

NCT02273141

Conditions
Colon Cleansing, Colonic Diseases, Colorectal Cancer, +11 more
Locations
  • Charité - Campus Virchow Klinikum Berlin, Germany
  • University Hospital Schleswig-Holstein Kiel, Germany
  • An der Germania Brauerei 6 Münster, Germany
  • An der Germania Brauerei 6 Milan, Italy
View all 19 locations
View Trial Details
Completed

E. Coli Nissle in Oncology

NCT02706184

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +12 more
Locations
  • Klinikum Ludwigsburg Ludwigsburg, Baden-Wurttemberg, Germany
  • Paracelsus-Krankenhaus Ruit Ostfildern, Baden-Wurttemberg, Germany
  • Klinikum am Steinenberg /Ermstalklinik Reutlingen, Baden-Wurttemberg, Germany
  • Klinikum Stuttgart Stuttgart, Baden-Wurttemberg, Germany
View Trial Details
Completed

Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus MOVIPREP® Using 2-Day Split-Dosing and 1-Day Morning Split-Dosing Regimen in Adults.

NCT02273167

Conditions
Colon Cleansing, Colonic Diseases, Colorectal Cancer, +11 more
Locations
  • AZ Sint-Lucas Bruges, Belgium
  • UZ Ghent Ghent, Belgium
  • UZ Leuven Leuven, Belgium
  • CHC- Clinique Saint-Joseph Liège, Belgium
View all 29 locations
View Trial Details
Completed

Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus Trisulfate Solution Using 2-Day Split-Dosing Regimen in Adults

NCT02254486

Conditions
Colon Cancer, Colon Cleansing, Colonic Diseases, +12 more
Locations
  • Anaheim Clinical Trials Anaheim, California, United States
  • Investigative Clinical Research Annapolis, Maryland, United States
  • MGG Group Co., Inc., Chevy Chase Clinical Chevy Chase, Maryland, United States
  • Clinical Research Institute of Michigan, LLC Chesterfield, Michigan, United States
View Trial Details

Related conditions